Paul S. Carbone, MD: Risk Factors for Autism Spectrum Disorder

Video

Children are now screened for autism at 18 and 24 months.

Identifying the maternal risk factors of autism spectrum disorder (ASD) could be beneficial for earlier screenings and treatment plans for patients.

In an interview with HCPLive®, Paul S. Carbone, MD, professor of pediatrics, University of Utah, explained some of the advancements in pediatric autism care that has occurred in recent years.

Adopting better screening methods and advancing treatment has been slow, but new evidence-based research is helping to improve care. For example, the majority of pediatricians autism screenings are now routine at the 18 and 24-month visits.

Carbone said in the last decade the knowledge on how to best manage and treat ASD has expanded and improved, based on a lot of new genetic discoveries about autism. There has also been advancements in learning exactly how autism unfolds in early years, which helps provide better treatment plans down the line.

And more regular screenings allows doctors to focus on the processes of care.

Another area of focus will be on co-occurring conditions, including gastrointestinal problems, sleep issues, and other psychiatric struggles, such as ADHD and stress.

Carbone will present 2 presentations during the 2021 American Academy of Pediatrics Virtual Conference that focus on autism beyond diagnosis, specifically on managing the disease.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.